Morgan Stanley’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.02M | Buy |
81,733
+38,633
| +90% | +$483K | ﹤0.01% | 5089 |
|
2025
Q1 | $750K | Buy |
43,100
+14,538
| +51% | +$253K | ﹤0.01% | 5139 |
|
2024
Q4 | $1.09M | Buy |
28,562
+5,207
| +22% | +$198K | ﹤0.01% | 5043 |
|
2024
Q3 | $781K | Buy |
23,355
+10,334
| +79% | +$345K | ﹤0.01% | 5181 |
|
2024
Q2 | $441K | Buy |
13,021
+5,352
| +70% | +$181K | ﹤0.01% | 5346 |
|
2024
Q1 | $690K | Sell |
7,669
-4,267
| -36% | -$384K | ﹤0.01% | 5161 |
|
2023
Q4 | $572K | Buy |
11,936
+11,232
| +1,595% | +$538K | ﹤0.01% | 5564 |
|
2023
Q3 | $13K | Buy |
704
+620
| +738% | +$11.5K | ﹤0.01% | 6632 |
|
2023
Q2 | $1.46K | Sell |
84
-1,648
| -95% | -$28.6K | ﹤0.01% | 7241 |
|
2023
Q1 | $43.6K | Buy |
1,732
+1,280
| +283% | +$32.2K | ﹤0.01% | 6333 |
|
2022
Q4 | $87K | Sell |
452
-148
| -25% | -$28.5K | ﹤0.01% | 6047 |
|
2022
Q3 | $54K | Sell |
600
-718
| -54% | -$64.6K | ﹤0.01% | 6372 |
|
2022
Q2 | $99K | Buy |
1,318
+279
| +27% | +$21K | ﹤0.01% | 6281 |
|
2022
Q1 | $110K | Sell |
1,039
-2,969
| -74% | -$314K | ﹤0.01% | 6247 |
|
2021
Q4 | $1.03M | Sell |
4,008
-6,568
| -62% | -$1.69M | ﹤0.01% | 5048 |
|
2021
Q3 | $3.73M | Sell |
10,576
-3,710
| -26% | -$1.31M | ﹤0.01% | 4025 |
|
2021
Q2 | $7.12M | Buy |
14,286
+14,015
| +5,172% | +$6.98M | ﹤0.01% | 3395 |
|
2021
Q1 | $129K | Sell |
271
-7,796
| -97% | -$3.71M | ﹤0.01% | 5881 |
|
2020
Q4 | $14.2M | Buy |
8,067
+7,834
| +3,362% | +$13.8M | ﹤0.01% | 2157 |
|
2020
Q3 | $225K | Sell |
233
-1,380
| -86% | -$1.33M | ﹤0.01% | 5044 |
|
2020
Q2 | $1.88M | Buy |
1,613
+1,516
| +1,563% | +$1.76M | ﹤0.01% | 3658 |
|
2020
Q1 | $86K | Sell |
97
-168
| -63% | -$149K | ﹤0.01% | 5244 |
|
2019
Q4 | $232K | Buy |
+265
| New | +$232K | ﹤0.01% | 5355 |
|